Viewing StudyNCT04396626



Ignite Creation Date: 2024-05-06 @ 2:41 PM
Last Modification Date: 2024-10-26 @ 1:35 PM
Study NCT ID: NCT04396626
Status: TERMINATED
Last Update Posted: 2023-04-27
First Post: 2020-04-28

Brief Title: HR HER2- Advanced Metastatic Breast Cancer Real World Treatment Patterns and Outcomes
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-11-18
Start Date Type: ACTUAL
Primary Completion Date: 2020-05-31
Primary Completion Date Type: ACTUAL
Completion Date: 2020-05-31
Completion Date Type: ACTUAL
First Submit Date: 2020-04-28
First Submit QC Date: May 18 2020
Study First Post Date: 2020-05-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2022-03-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-31
Last Update Post Date: 2023-04-27
Last Update Post Date Type: ACTUAL